FONDAZIONE ANGELO BIANCHI BONOMI
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Type 3 Von Willebrand International Registries Inhibitor Prospective Study
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Fondazione Angelo Bianchi Bonomi
- Target Recruit Count
- 265
- Registration Number
- NCT02460458
- Locations
- 🇫🇮
Helsinki University Central Hospital, Department Internal Medicine, Coagulation Disorders, at Haematology and Laboratory Services, Helsinki, Finland
🇫🇷Institut d'Hématologie - Hôpital Cardiologique - University of Lille - Haematology Department, Lille Cedex, France
🇫🇷Centre Régional de Traitement de l'Hémophilie - Laboratoire d'Hématologie, Nantes Cedex 1, France
Survey of Inhibitors in Plasma-Product Exposed Toddlers
- Conditions
- Hemophilia A
- Interventions
- Drug: Recombinant FVIII
- First Posted Date
- 2010-02-08
- Last Posted Date
- 2017-08-25
- Lead Sponsor
- Fondazione Angelo Bianchi Bonomi
- Target Recruit Count
- 303
- Registration Number
- NCT01064284
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸Children's Hospital Los Angeles (CHLA), Los Angeles, California, United States
🇺🇸Hemophilia and Thrombosis CenterUniversity of Colorado Denver - Anschutz Aurora, Aurora, Colorado, United States